These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS). Walker JL; Wang SS; Schiffman M; Solomon D; Am J Obstet Gynecol; 2006 Aug; 195(2):341-8. PubMed ID: 16890545 [TBL] [Abstract][Full Text] [Related]
7. The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment. Ronco G; Brezzi S; Carozzi F; Dalla Palma P; Giorgi-Rossi P; Minucci D; Naldoni C; Segnan N; Zappa M; Zorzi M; Cuzick J; Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S230-2. PubMed ID: 17822751 [TBL] [Abstract][Full Text] [Related]
8. The clinical utility of HPV DNA testing in cervical cancer screening strategies. Bhatla N; Moda N Indian J Med Res; 2009 Sep; 130(3):261-5. PubMed ID: 19901435 [TBL] [Abstract][Full Text] [Related]
9. Integrating human papillomavirus vaccination in cervical cancer control programmes. Franco EL; Coutlée F; Ferenczy A Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447 [TBL] [Abstract][Full Text] [Related]
10. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples. Cibas ES; Hong X; Crum CP; Feldman S Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245 [TBL] [Abstract][Full Text] [Related]
11. Re: A study of the impact of adding HPV types to cervical cancer screening and triage tests. Franceschi S; Clifford GM J Natl Cancer Inst; 2005 Jun; 97(12):938-9; author reply 939-41. PubMed ID: 15956659 [No Abstract] [Full Text] [Related]
12. Patient safety and the next generation of HPV DNA tests. Lee SH Am J Clin Pathol; 2011 Mar; 135(3):481; author reply 482-3. PubMed ID: 21350106 [No Abstract] [Full Text] [Related]
13. Human papillomavirus and cervical cancer: not just a sexually transmitted disease. Likes WM; Itano J Clin J Oncol Nurs; 2003; 7(3):271-6. PubMed ID: 12793333 [TBL] [Abstract][Full Text] [Related]
14. Special commentary: patient safety and the next generation of HPV DNA tests. Kinney W; Stoler MH; Castle PE Am J Clin Pathol; 2010 Aug; 134(2):193-9. PubMed ID: 20660320 [TBL] [Abstract][Full Text] [Related]
15. [Research progression on triage of human papillomavirus positive women]. Li JX; Dong L; Li L; Cheng W Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):641-646. PubMed ID: 30293386 [TBL] [Abstract][Full Text] [Related]
16. The promise of global cervical-cancer prevention. Schiffman M; Castle PE N Engl J Med; 2005 Nov; 353(20):2101-4. PubMed ID: 16291978 [No Abstract] [Full Text] [Related]
17. Human papillomavirus (HPV) typing as an adjunct to cervical cancer screening. Syrjänen KJ; Syrjänen SM Cytopathology; 1999 Feb; 10(1):8-15. PubMed ID: 10068882 [No Abstract] [Full Text] [Related]
18. Cervical cancer screening following prophylactic human papillomavirus vaccination. Franco EL; Cuzick J Vaccine; 2008 Mar; 26 Suppl 1():A16-23. PubMed ID: 18642468 [TBL] [Abstract][Full Text] [Related]
19. Cervical screening in England: the past, present, and future. Albrow R; Kitchener H; Gupta N; Desai M Cancer Cytopathol; 2012 Apr; 120(2):87-96. PubMed ID: 22367883 [TBL] [Abstract][Full Text] [Related]
20. [Human papilloma virus (HPV) testing for cervical carcinoma screening]. Nocon M; Roll S; Mittendorf T; von der Schulenburg JM; Willich SN Z Evid Fortbild Qual Gesundhwes; 2010; 104(2):138-42. PubMed ID: 20441022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]